A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655
ZOLL Medical Corporation
+1 (978) 421-9637
ZOLL Medical To Ring Opening Bell At NASDAQ Stock Market
Ceremony Commemorates 15 Years as a Publicly Traded Company
July 12, 2007 — CHELMSFORD ,MASS. – ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that Richard A. Packer, President and CEO, will ring the ceremonial NASDAQ stock market opening bell on Tuesday, July 17th at 9:30 a.m. ET at the NASDAQ MarketSite in Times Square, New York City. Mr. Packer will be joined by a group of ZOLL employees, who were employed by ZOLL when the company went public in 1992, to mark this year’s 15th anniversary on The NASDAQ Stock Market.
"Opening NASDAQ is a tremendous honor as well as a great opportunity for us to thank everyone who has supported us and helped us get here today,” said Mr. Packer. “Today’s emerging resuscitation market is more than just defibrillation. Going forward, I believe ZOLL is well-positioned to continue to make pioneering inroads into the advancement of resuscitation technology in areas such as circulation, fluid delivery, ventilation, hypothermia, data analysis, and electrical therapy where there is still a large unmet clinical opportunity.”
Over the past 15 years, ZOLL has continued to introduce highly differentiated resuscitation products that have aided hospitals, emergency services providers and lay rescuers to save the lives of patients who suffer sudden cardiac arrest—the leading cause of death in the United States. Some of the Company’s products today include AutoPulse®, a revolutionary automated chest compression system; R Series™, a Code-Ready™ defibrillator that is simple, smart, and ready to use in hospital codes; the AED Plus® with Real CPR Help™, an automated external defibrillator that allows rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions; CodeNet®, a software system that allows hospital teams to better document, manage, and review cardiac arrest event and resuscitation information; RescueNet™, the only fully integrated suite of EMS data management solutions that lets EMS organizations manage critical information for maximum performance; and LifeVest®, the only wearable defibrillator.
Legacy of Significant Growth and Expansion
With the incorporation of noninvasive cardiac pacing in American Heart Association Guidelines, ZOLL went public as a defibrillator company in 1992 and generated annual sales of $21.3 million. Since then, ZOLL has increased annual revenues 12-fold and generated profitability every year.
Additional benchmarks reflecting the Company’s growth:
- Market cap has grown from $54.6 million at the IPO price to more than $400 million currently;
- Number of employees has grown from 125 full time employees to over 1,200 today;
- International sales have grown from a nominal level in a small number of countries to more than $55 million sold in over 140 countries.
Satellite Feed Information
The NASDAQ ceremony will be made available to press via live satellite feed. The opening bell feed is available from9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto of NASDAQ MarketSite at (646) 441-5220.
A live Webcast of the NASDAQ Opening Bell will also be available at: http://www.nasdaq.com/reference/marketsite_about.stm
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.
Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on May 11, 2007.
©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. Code-Ready, Real CPR Help™, RescueNet, and R Series are trademarks of ZOLL Medical Corporation. AutoPulse, AED Plus, CodeNet, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.